{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T13:41:30Z","timestamp":1790343690035,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["0068744"],"award-info":[{"award-number":["0068744"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ejps.2025.107072","type":"journal-article","created":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T15:57:38Z","timestamp":1742054258000},"page":"107072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Evaluating polymer influence on resuspendability of indomethacin suspensions produced by microfluidization"],"prefix":"10.1016","volume":"209","author":[{"given":"Mathias Dam M\u00f8nster","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Parhizkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-7765","authenticated-orcid":false,"given":"Ren\u00e9","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejps.2025.107072_bib0001","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.apsb.2018.07.011","article-title":"Parenteral nanosuspensions: a brief review from solubility enhancement to more novel and specific applications","volume":"8","author":"Ahire","year":"2018","journal-title":"Acta Pharm. Sin. B"},{"issue":"9","key":"10.1016\/j.ejps.2025.107072_bib0002","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1021\/acs.molpharmaceut.4c00665","article-title":"Patient-centric long-acting injectable and implantable platforms - an industrial perspective","volume":"21","author":"Alidori","year":"2024","journal-title":"Mol. Pharm."},{"issue":"14","key":"10.1016\/j.ejps.2025.107072_bib0003","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1517\/14656566.2010.499125","article-title":"Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention","volume":"11","author":"Agid","year":"2010","journal-title":"Expert. Opin. PharmacOther"},{"issue":"3","key":"10.1016\/j.ejps.2025.107072_bib0004","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ejpb.2009.03.006","article-title":"Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment","volume":"72","author":"Baert","year":"2009","journal-title":"Eur. J. Pharm. Biopharm.: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107072_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cis.2004.07.003","article-title":"Flocculation of cellular suspensions by polyelectrolytes","volume":"111","author":"Barany","year":"2004","journal-title":"Adv. Colloid. Interface Sci."},{"issue":"8","key":"10.1016\/j.ejps.2025.107072_bib0006","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.ejps.2025.107072_bib0007","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejpb.2018.01.013","article-title":"Preparation of amorphous indomethacin nanoparticles by aqueous wet bead milling and in situ measurement of their increased saturation solubility","volume":"125","author":"Colombo","year":"2018","journal-title":"Eur. J. Pharm. Biopharm.: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.ejps.2025.107072_bib0008","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0076-6879(01)39318-7","article-title":"Micellar systems as solvents in peptide and protein structure determination","volume":"339","author":"Damberg","year":"2001","journal-title":"Meth. Enzymol."},{"issue":"7","key":"10.1016\/j.ejps.2025.107072_bib0009","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/jps.24014","article-title":"Intramuscular administration of paliperidone palmitate extended-release injectable microsuspension induces a subclinical inflammatory reaction modulating the pharmacokinetics in rats","volume":"103","author":"Darville","year":"2014","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.ejps.2025.107072_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0939-6411(99)00045-4","article-title":"Dose uniformity and redispersibility of pharmaceutical suspensions. I: quantification and mechanical modelling of human shaking behaviour","volume":"48","author":"Deicke","year":"1999","journal-title":"Eur. J. Pharm. Biopharm.: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V"},{"key":"10.1016\/j.ejps.2025.107072_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119094","article-title":"Towards an improved understanding of drug excipient interactions to enable rapid optimization of nanosuspension formulations","volume":"578","author":"Ferrar","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107072_bib0012","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejps.2012.10.004","article-title":"Identifying the correlation between drug\/stabilizer properties and critical quality attributes (CQAs) of nanosuspension formulation prepared by wet media milling technology","volume":"48","author":"George","year":"2013","journal-title":"Eur. J. Pharm. Sci.: Official J. Eur. Fed. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejps.2025.107072_bib0013","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2165\/11631310-000000000-00000","article-title":"Long-acting injectable antipsychotics for the maintenance treatment of bipolar disorder","volume":"26","author":"Gigante","year":"2012","journal-title":"CNS. Drugs"},{"issue":"8","key":"10.1016\/j.ejps.2025.107072_bib0014","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/17425247.2022.2105318","article-title":"Long-acting injectable formulation technologies: challenges and opportunities for the delivery of fragile molecules","volume":"19","author":"Gonella","year":"2022","journal-title":"Expert. Opin. Drug Deliv."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107072_bib0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ijpharm.2017.07.047","article-title":"Dual centrifugation - a new technique for nanomilling of poorly soluble drugs and formulation screening by an DoE-approach","volume":"530","author":"Hagedorn","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"23","key":"10.1016\/j.ejps.2025.107072_bib0016","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1002\/1521-3773(20011203)40:23<4330::AID-ANIE4330>3.0.CO;2-W","article-title":"Organic nanoparticles in the aqueous phase-theory, experiment, and use","volume":"40","author":"Horn","year":"2001","journal-title":"Angew. Chem. Int. Ed. Engl."},{"issue":"3","key":"10.1016\/j.ejps.2025.107072_bib0017","first-page":"295","article-title":"Nanocrystal technology, drug delivery and clinical applications","volume":"3","author":"Junghanns","year":"2008","journal-title":"Int. J. Nanomedicine"},{"issue":"7","key":"10.1016\/j.ejps.2025.107072_bib0018","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.addr.2007.05.003","article-title":"Nanosizing\u2013oral formulation development and biopharmaceutical evaluation","volume":"59","author":"Kesisoglou","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2025.107072_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.powtec.2023.118829","article-title":"A comparative study of dry and wet top-down milling approaches for the preparation of microparticle suspensions","volume":"428","author":"M\u00e9ndez Ca\u00f1ellas","year":"2023","journal-title":"Powder. Technol."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107072_bib0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijpharm.2018.05.042","article-title":"Comparison of high pressure homogenization and stirred bead milling for the production of nano-crystalline suspensions","volume":"547","author":"Nakach","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107072_bib0021","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijpharm.2014.09.048","article-title":"Engineering of nano-crystalline drug suspensions: employing a physico-chemistry based stabilizer selection methodology or approach","volume":"476","author":"Nakach","year":"2014","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ejps.2025.107072_bib0022","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1080\/14740338.2016.1201475","article-title":"An update of safety of clinically used atypical antipsychotics","volume":"15","author":"Orsolini","year":"2016","journal-title":"Expert. Opin. Drug Saf."},{"issue":"6","key":"10.1016\/j.ejps.2025.107072_bib0023","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.chempr.2020.05.002","article-title":"Molecular Representation: going Long on Fingerprints","volume":"6","author":"Pattanaik","year":"2020","journal-title":"Chem."},{"issue":"2","key":"10.1016\/j.ejps.2025.107072_bib0024","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.carbpol.2010.08.018","article-title":"Flocculating and suspending properties of commercial citrus pectin and pectin extracted from pomelo (Citrus maxima) peel","volume":"83","author":"Pririyaprasarth","year":"2011","journal-title":"Carbohydr. Polym."},{"issue":"9","key":"10.1016\/j.ejps.2025.107072_bib0025","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrd1494","article-title":"Nanosuspensions in drug delivery","volume":"3","author":"Rabinow","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"1","key":"10.1016\/j.ejps.2025.107072_bib0026","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1574884715666200309121932","article-title":"Long-acting injectable vs. oral antipsychotics: adherence, persistence and switching over three years of real-life analysis","volume":"16","author":"Romagnoli","year":"2021","journal-title":"Curr. Rev. Clin. Exp. Ph."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107072_bib0027","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijpharm.2009.06.029","article-title":"Effect of wet milling process on the solid state of indomethacin and simvastatin","volume":"380","author":"Sharma","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107072_bib0028","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jcrysgro.2016.10.005","article-title":"Crystallisation of sodium dodecyl sulfate and the corresponding effect of 1-dodecanol addition","volume":"455","author":"Summerton","year":"2016","journal-title":"J. Cryst. Growth"},{"issue":"2","key":"10.1016\/j.ejps.2025.107072_bib0029","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/pharmaceutics8020016","article-title":"Stabilizing agents for drug nanocrystals: effect on bioavailability","volume":"8","author":"Tuomela","year":"2016","journal-title":"Pharmaceutics."},{"issue":"1","key":"10.1016\/j.ejps.2025.107072_bib0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.07.023","article-title":"Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products","volume":"364","author":"Van Eerdenbrugh","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ejps.2025.107072_bib0031","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.ejps.2025.107072_bib0032","doi-asserted-by":"crossref","first-page":"270","DOI":"10.9740\/mhc.2022.10.270","article-title":"An update on recently approved long-acting injectable second-generation antipsychotics: knowns and unknowns regarding their use","volume":"12","author":"Vandenberg","year":"2022","journal-title":"Ment. Health Clin."},{"issue":"1\u20132","key":"10.1016\/j.ejps.2025.107072_bib0033","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijpharm.2010.12.027","article-title":"Physical stability of nanosuspensions: investigation of the role of stabilizers on Ostwald ripening","volume":"406","author":"Verma","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107072_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2022.110735","article-title":"Machine learning predicts electrospray particle size","volume":"219","author":"Wang","year":"2022","journal-title":"Mater. Des."},{"issue":"3","key":"10.1016\/j.ejps.2025.107072_bib0035","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jconrel.2013.08.006","article-title":"Stability of nanosuspensions in drug delivery","volume":"172","author":"Wang","year":"2013","journal-title":"J. Contr. Release: Official J. Contr. Release Soc."},{"issue":"4","key":"10.1016\/j.ejps.2025.107072_bib0036","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3109\/10837450.2011.614252","article-title":"Sedimentation and resuspendability evaluation of pharmaceutical suspensions by low-field one dimensional pulsed field gradient NMR profilometry","volume":"18","author":"Wuxin","year":"2013","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.ejps.2025.107072_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123455","article-title":"Wet bead milling by dual centrifugation - an approach to obtain reproducible and differentiable suspensions","volume":"646","author":"Zulbeari","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2025.107072_bib0038","article-title":"Small-scale aqueous suspension preparation using dual centrifugation: the effect of process parameters on the sizes of drug particles","volume":"205","author":"Zulbeari","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejps.2025.107072_bib0039","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijpharm.2013.06.004","article-title":"Statistical analysis of the effects of polyethylene glycol concentration and molecular weight on the sedimentation and resuspendability behavior of model aqueous dispersions","volume":"453","author":"Zhu","year":"2013","journal-title":"Int. J. Pharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000715?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098725000715?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:06:48Z","timestamp":1760227608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098725000715"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":39,"alternative-id":["S0928098725000715"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107072","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating polymer influence on resuspendability of indomethacin suspensions produced by microfluidization","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2025.107072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107072"}}